Connect with us

Latest News

UAE launches COVID-19 vaccine production with China’s Sinopharm

Published

on

Reuters

A new factory in Abu Dhabi will start manufacturing a COVID-19 vaccine from Chinese pharmaceutical giant Sinopharm later this year under a joint venture between Sinopharm and Abu Dhabi-based technology company Group 42 (G42).

The project is an expansion of Chinese diplomacy in the Gulf region and helps the United Arab Emirates’ quest to diversify its economy away from hydrocarbon production.

The plant, which is being built in the Khalifa Industrial Zone of Abu Dhabi (KIZAD), will have a production capacity of 200 million doses a year with three filling lines and five automated packaging lines, a statement from the joint venture said on Monday.

The vaccine will be called Hayat-Vax when manufactured in the UAE, but is the same inactivated vaccine from the Beijing Institute of Biological Product (BiBP), a unit of Sinopharm’s China National Biotec Group (CNBG), that the UAE approved for general use in December.

As part of the joint venture, interim production of Hayat-Vax has already begun in the emirate of Ras al-Khaimah under a deal between G42 and Gulf Pharmaceutical Industries PSC, the statement said.

That interim production line has an initial capacity of 2 million doses per month and no details were given about how long production will continue there.

The UAE, through G42, hosted Phase III clinical trials of the Sinopharm vaccine from July, which later expanded to other countries in the region including Bahrain. The UAE approved the vaccine for frontline workers in September before making it available to the general public in December.

G42 has previously said it has distribution and manufacturing agreements with Sinopharm and hopes to provide the UAE and other states in the region with the vaccine.

The deal was launched during a two-day visit to the UAE by Chinese Foreign Minister Wang Yi which ended on Sunday.

The joint venture also includes a purpose-built research and development hub for life sciences, biotechnology and vaccine production in KIZAD.

“Our joint venture is also actively looking to bring our capabilities to new markets around the world,” G42 CEO Peng Xiao said.

The UAE has said its trials showed the vaccine has 86% efficacy, while Sinopharm reports 79.34% efficacy based on interim results.

Some people in the UAE failed to develop sufficient antibodies after a second dose of the Sinopharm vaccine and were given a third dose, the UAE health ministry said this month. It said the number was “minimal” compared to the number of vaccines administered.

On Sunday, a Sinopharm executive said the company will need to assess results from overseas Phase III clinical trials to decide whether its two-shot vaccine should be followed by a booster shot.

“Thanks to the close collaboration with the UAE, Sinopharm’s vaccine has been now administered to millions of people in the country, the region, and the world,” Sinopharm Chairman Liu Jingzhen said at a virtual launch also attended by UAE Foreign Affairs Minister Sheikh Abdullah bin Zayed Al Nahyan.

Latest News

Ministries of Public Health and Higher Education sign cooperation agreement

Published

on

The Ministry of Public Health announced on Tuesday it has signed a cooperation agreement with the Ministry of Higher Education aimed at expanding scientific, research, educational, and technical cooperation.

At the signing ceremony held in Kabul, Noor Jalal Jalali, Minister of Public Health, said that the agreement would lead to significant improvements in the capacity-building of students and doctors, ensure that research is conducted based on evidence, and enable the collection of accurate data.

Meanwhile, Neda Mohammad Nadeem, Minister of Higher Education, described the agreement as beneficial to the public and to both institutions, stressing the need to train individuals at universities who can contribute to social development and make the country self-sufficient in the public health sector.

Continue Reading

Latest News

UNAMA holds new round of Working Group meetings on counter-narcotics and private sector

Published

on

The United Nations Assistance Mission in Afghanistan (UNAMA) has convened a new round of Doha Process Working Group meetings focusing on counter-narcotics and private sector development.

The meetings, held in Kabul on February 3 and 9, brought together representatives of UN member states and international organizations, officials of the Islamic Emirate, and subject-matter experts.

According to UNAMA, discussions in the counter-narcotics working group centered on efforts by Islamic Emirate authorities and the international community to support alternative livelihoods for Afghans previously dependent on poppy cultivation and the illicit opium trade. Participants also reviewed drug-use prevention and treatment initiatives, as well as law-enforcement measures to curb narcotics production and trafficking.

The private sector working group focused on job creation and entrepreneurship, with particular attention to women’s participation in the private sector, market integration, access to finance, and the development of private banking and financial infrastructure.

UNAMA said both working groups identified priority areas for enhanced engagement and explored more effective and sustainable approaches to supporting Afghan men and women. Participants also examined the linkages between the two areas, noting that private sector development is a key source of livelihoods, while counter-narcotics efforts contribute to Afghanistan’s economic and social stability.

The working groups were established following the third Meeting of Special Envoys held in Doha, Qatar, in June and July 2024, in line with recommendations of the Independent Assessment endorsed by the UN Security Council. The process aims to promote more coherent, coordinated, and structured engagement with Afghanistan’s de facto authorities for the benefit of the Afghan people.

UNAMA added that stakeholders engage in the working groups on an ongoing basis, with full-format meetings convened periodically. Since their establishment, the groups have improved information-sharing, helped mobilize additional resources, and facilitated expert exchanges to strengthen support for the Afghan people.

Continue Reading

Latest News

Economic Commission approves national policy for development of agriculture

Published

on

At a regular meeting of the Economic Commission chaired by Mullah Abdul Ghani Baradar, Deputy Prime Minister for Economic Affairs, the National Policy for the Development of the Agriculture and Livestock Sector was approved.

According to a statement from the deputy PM’s office, the key objectives of the policy include the mechanization of the agriculture and livestock sector; development of agricultural, irrigation, and livestock research and extension systems; management of irrigation systems; support for investment in these sectors; and ensuring public access to high-quality agricultural and animal products.

During the same meeting, the development plan for the fish farming sector was also approved.

Under this plan, through private sector investment, 7,700 small, medium, and large fish production and farming facilities will be established on 6,500 hectares of land in various parts of the country.

The statement added that the implementation of this plan will create direct employment opportunities for 50,000 people and indirect employment for 250,000 others.

Continue Reading
Advertisement
Advertisement
Advertisement
Advertisement

Trending

Copyright © 2025 Ariana News. All rights reserved!